First-in-class anaemia therapy granted expanded approval
11 April 2024
The expanded authorisation of Reblozyl is based on a Phase III trial which showed that the treatment nearly doubled the percentage of certain transfusion-dependent anaemia patients achieving haemoglobin increase, compared to epoetin alfa.
Two mental health centers will open in pilot mode in Moscow
11 April 2024
The Deputy Mayor of Moscow, Anastasia Rakova, has announced the upcoming opening of two mental health centers in the Russian capital, which will operate in experimental mode. “We have decided to open mental health centers in Moscow, where Muscovites will be offered comprehensive psychological and psychotherapeutic assistance,” she told reporters.
Antibody-immunotherapy treatment shows benefit in serious endometrial cancer
10 April 2024
The novel combination cancer therapy facilitated “exceptional” responses in some patients enrolled in a Phase II study for endometrial cancer.
mRNA therapy could provide intracellular protein replacement for rare disease
10 April 2024
With no treatments approved for propionic acidaemia, Moderna’s LNP-encapsulated mRNA therapy could offer a new therapeutic option for patients, new data suggests.
Nicaragua to Establish Nuclear Medicine Center with Russian Support
09 April 2024
The government of Nicaragua announced on Tuesday that it plans to build, with support from Russia, a Nuclear Medicine Center specialized in cancer treatment and in the training of professionals in the area. A delegation from the Nicaraguan Ministry of Health signed a memorandum with representatives of the Russian state-owned Rosatom Health Technologies in the Russian city of Sochi, said Nicaraguan Vice President Rosario Murillo to the Sandinista television channel Canal 4.
Russia opens three healthcare institutions daily
09 April 2024
The city authorities have decided to include drugs containing the active substance inclisiran. It is in the list of free drugs provided to Muscovites with hyperlipidemia. The corresponding resolution was signed by Sergei Sobyanin. In 2023, over 169 thousand Muscovites were provided with free drugs.
08 April 2024
In the urban areas of Chernogolovka, Dubna, Korolev, and Dolgoprudny, located in the Moscow region, there are plans to construct two new plants, as well as modernize two existing ones. The enterprises will launch production of import-substituting products in the field of medicine and pharmaceuticals. The Moscow Region Ministry of Investment, Industry, and Science estimates the total investment volume at 5.2 billion rubles.
Russia to collaborate with Hungary and Serbia in nuclear medicine
08 April 2024
Hungary, Serbia, and Russia have agreed to collaborate on joint projects in the field of nuclear medical technologies, focusing on cancer treatment. This agreement was reached during the international forum Atomexpo-2024, held in Sochi.
A new medical glass production facility will be established in Mordovia
04 April 2024
A factory will be constructed within the Sistema special economic zone (SEZ) in Saransk, Republic of Mordovia, for the purpose of manufacturing medical glass for the pharmaceutical industry. The head of the region, Artem Zdunov, announced this in his Telegram channel.
Could immunotherapy prevent breast cancer before it starts?
04 April 2024
Researchers for the first time have identified dysfunctional immune cells in the healthy breast tissue of women with mutations in the genes BRCA1 and BRCA2, a finding that opens up the possibility of using existing immunotherapy drugs to prevent cancer before it forms.
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Big Pharma’s ROI for drug R&D saw 'welcome' rebound in 2023: report
25 April 2024
Orphan drug market to reach $270B by 2028 : Evaluate
25 April 2024
Russian drug for the treatment of viral hepatitis will be exempt from duty in Mongolia
24 April 2024
PM Mishustin: “We need to increase the production of vital and essential drugs in Russia”
24 April 2024